The current valuation score of Ocugen Inc is 6.35, ranking 340 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.56, which is -82.25% below the recent high of -0.99 and -105.83% above the recent low of -11.44.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.